FDA Inspection 1254518 — Manhattan Drug Co. Inc
The FDA completed an inspection of Manhattan Drug Co. Inc on Aug 14, 2025 in Hillside, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 14, 2025
- Fiscal Year
- 2025
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Hillside, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15702 | 21 CFR 111.320(b) | Examination, testing; scientifically valid |
| 15963 | 21 CFR 111.113(b)(2) | Quality control - reject; specification not met |
| 22843 | 21 CFR 111.70(b) | Specifications - components |
| 22888 | 21 CFR 111.210 | Master manufacturing record - record requirements |